Roche is paying $20 million upfront to secure rights to two degrader-antibody conjugates (DACs) for cancer developed by longtime partner C4T.

Boehringer has altered the terms of its digital therapeutic alliance with Click on schizophrenia app CT-155, taking a more strategic investor role.

Novartis is launching a three-front push to close healthcare gaps in heart disease and cancer, expanding initiatives with the goal of roughly tripling their footprint

AbbVie filed suit against the federal government on Wednesday over its interpretation of the word “patient” under the 340B federal drug discount program. The lawsuit

Deals deals deals. Biopharma M&A is having one of its best stretches in years, as big pharma buyers snap up smaller biotechs. We’ll be talking